Eales disease is a rare eye condition that causes inflammation and blockage in the small blood vessels of the retina. Early symptoms of Eales disease often include floaters, blurred vision, or sudden loss of part of the vision, and it most often affects young adults. Not everyone will have the same experience. Eales disease can last for years and may flare up over time, but it usually does not affect overall life expectancy. Treatment for Eales disease often includes steroid medicines, laser treatment, and sometimes surgery if bleeding or retinal damage becomes severe.
How many people live with Eales disease?
Global and U.S. prevalence estimates for Eales disease are not consistently reported by a single authoritative source, so there is no reliable recent count of how many people are living with it worldwide or in the United States. It is generally described as a rare eye condition, and many published reports come from South Asia, but firm population totals are lacking.
Overview
Eales diseaseSymptoms
Eales disease often causes floaters, blurred vision, and patches of missing sight. Many with Eales disease notice these episodes in one or both eyes, and bleeding inside the eye can sometimes lead to sudden vision loss.
Outlook and prognosis
The outlook for Eales disease is often good when bleeding and retinal damage are found and treated early. Many living with Eales disease keep useful vision, though flare-ups can happen. Prognosis is less favorable if repeated bleeding or retinal detachment develops.
Causes and risk factors
The exact cause of Eales disease is unclear. Risk seems higher in young adults, especially men, and in some South Asian groups. Prior exposure to tuberculosis may trigger an abnormal immune response, while smoking may worsen inflammation and complications.
Genetic influences
Genetics do not appear to be the main cause of Eales disease. Some genetic variations may affect immune responses and susceptibility, but the exact role of inherited factors in Eales disease is still unclear.
Diagnosis
Diagnosis of Eales disease usually starts with an eye exam after blurred vision or floaters. Eye specialists use retinal imaging, including fluorescein angiography, to look for typical changes. Blood tests and scans may help rule out other causes.
Treatment and drugs
Treatment for Eales disease focuses on controlling eye inflammation, treating areas of poor blood flow in the retina, and preventing bleeding. Many living with Eales disease may need steroid medicines, laser treatment, and sometimes eye surgery if bleeding does not clear.
Symptoms
Eales disease often affects vision in fits and starts, so someone may feel fine for a while and then suddenly notice new spots, haze, or a drop in sight. The early symptoms of Eales disease can be subtle, especially if only one eye is affected, and many people first notice trouble when reading, driving, or looking into bright light. Symptoms vary from person to person and can change over time. As the condition becomes more active, bleeding inside the eye can cause a sudden, painless change in vision.
Many people with Eales disease notice dark specks, cobwebs, or drifting shadows in their vision. These can come and go, or they may appear suddenly if there is bleeding inside the eye.
Vision may look hazy, smeared, or less sharp than usual. For many, this is most obvious when reading small print, recognizing faces, or trying to focus across a room.
A quick, painless drop in sight can happen if blood leaks into the clear gel inside the eye. Some may find that part of the view is blocked, while others notice that everything suddenly looks much darker or cloudier.
Some people see brief flickers or flashes, especially in dim light. This can happen when the retina is irritated, and it should be checked promptly if it is new or worsening.
How people usually first notice Eales disease?
Many people first notice Eales disease when their vision suddenly seems off in one eye, with new floaters, blurred sight, or dark patches that can look like smoke, cobwebs, or a curtain drifting across part of what they see. These first warning signs often happen because fragile blood vessels in the retina, the light-sensitive layer at the back of the eye, start to bleed. For many, the changes come and go at first, which can make them easy to dismiss, but any sudden new floaters or blurred vision should be checked by an eye doctor promptly.
Types of Eales disease
Eales disease can affect day-to-day vision in different ways depending on which phase is most active. Doctors sometimes classify symptoms as inflammatory versus ischemic, with a later proliferative phase when fragile new blood vessels grow. Symptoms don’t always look the same for everyone. When people ask about the types of Eales disease, they are usually talking about these clinical phases rather than separate diseases.
Inflammatory phase
This early phase often causes mild symptoms or none at all, so many people do not notice a problem right away. Some may have floaters, blurred vision, or brief hazy spots if there is inflammation in the veins of the retina.
Ischemic phase
In this phase, parts of the retina do not get enough blood flow, which can lead to dimmer vision or areas of missing sight. For many, this can mean trouble noticing objects off to one side or difficulty seeing clearly in low light.
Proliferative phase
Here, the eye grows delicate new blood vessels in response to poor blood flow, and these vessels can bleed easily. This often causes a sudden shower of floaters, cloudy vision, or a dark curtain-like change if bleeding is heavier.
Mixed phases
Many living with Eales disease have signs of more than one phase at the same time rather than a neat step-by-step pattern. The balance of symptoms can shift over time, so a person with mild floaters at first may later notice more abrupt vision changes if bleeding develops.
Can I slow down the onset of symptoms?
No one has shown that lifestyle changes can reliably delay Eales disease from starting, so the honest answer is that this is unclear and there is no proven way to prevent its onset. General healthy habits like not smoking and taking care of your overall health may support eye and blood vessel health, but they have not been proven to postpone this disease, and research in this area is limited. What can help is acting early if you notice floaters, blurred vision, or flashes of light, because prompt care from an eye specialist may limit damage after the disease begins, even though it does not stop it from starting.
What genetics can tell you about symptoms
For people with Eales disease, genetics may play a small role in who is more likely to develop the condition, but there is no well-established gene change that clearly predicts which symptoms will happen, how severe they will be, or when they will start. In day-to-day terms, two people can have very different experiences, from mild floaters or blurred vision to repeated bleeding inside the eye, and current genetic knowledge cannot reliably forecast that pattern. Right now, doctors rely much more on eye exams, imaging, and how the disease behaves over time than on genetic testing when judging symptoms.
Causes and risk factors
When floaters or blurry vision appear with Eales disease, the trouble usually starts with inflammation in the tiny veins of the retina at the back of the eye. The exact causes of Eales disease are not fully understood, but many cases are linked to an immune reaction after exposure to tuberculosis, including a silent infection. Risk factors for Eales disease include young adult age, male sex, and living in regions where tuberculosis is more common. Genes may shape how strongly the immune system reacts, but Eales disease is not known to come from one single inherited gene change. Researchers are still learning how these pieces fit together, and no specific diet, exercise habit, or daily activity has been proven to cause it.
What are the most common causes or risk factors?
The exact cause of Eales disease is still not clear, but the strongest link is past exposure to tuberculosis, where the body’s defense system may overreact and cause inflammation in the blood vessels at the back of the eye. It most often affects young adults and is seen more often in men, and it has been reported more often in South Asian populations, especially in India. There is no single clearly proven inherited gene cause, so family history is not thought to be a main risk factor for most people with Eales disease.
Environmental and biological risk factors
Eales disease is uncommon, and doctors do not know one single cause. The main risk factors for Eales disease seem to involve a strong immune response in the blood vessels of the eye, often linked to past tuberculosis exposure. Doctors often group risks into internal (biological) and external (environmental).
Past or latent tuberculosis infection is the risk factor most often linked with Eales disease. In many people with Eales disease, the problem seems to be an immune reaction to tuberculosis-related proteins, even without signs of active tuberculosis.
An overly strong inflammatory response in the small blood vessels of the retina is thought to raise risk. This helps explain why Eales disease is considered an immune-driven condition in many cases.
Eales disease is most often diagnosed in the late teens through the 30s. Age does not cause the condition by itself, but this pattern suggests that biology in early adult life may make the disease more likely.
Eales disease is reported more often in males than in females. The reason is not fully understood, but this difference has been seen repeatedly in clinical studies.
Genetic risk factors
Most people living with Eales disease do not have a clear inherited cause. Researchers think genes may affect how the immune system behaves in some people, but no single gene has been proven to cause Eales disease. That means genetic risk is possible, yet it remains uncertain and does not explain most cases on its own.
No single gene: Eales disease has no confirmed single-gene cause, and most people with it do not have a known inherited mutation. When people ask whether Eales disease is hereditary, the best current answer is that genetics may affect susceptibility, but the condition is not known to follow a clear inherited pattern.
HLA types: Some studies have linked Eales disease with certain HLA tissue-marker types, especially in specific populations. These genes help shape immune responses, so they may slightly raise susceptibility in some people, but they cannot reliably predict who will develop the disease.
Inflammation genes: Researchers have also looked at gene variants involved in inflammation and blood vessel injury in Eales disease. Science continues to uncover how these elements interact, but these findings are not strong or consistent enough for routine genetic testing.
Family history: Eales disease usually does not run strongly in families, and having a close relative with it is not considered a common genetic risk factor. A few family clusters have been reported, but this does not show a simple or well-established inherited pattern.
Lifestyle risk factors
No single lifestyle habit is known to directly cause Eales disease, but some daily habits can affect retinal blood vessel health, inflammation, and the risk of vision-threatening complications. When people ask about lifestyle risk factors for Eales disease, the most relevant issues are smoking, vascular health, exercise intensity, alcohol use, and how well related conditions are managed. Diet and activity do not replace medical treatment, but they can influence bleeding risk, recovery, and overall eye health.
Smoking can worsen blood vessel injury and inflammation, which may aggravate retinal ischemia and neovascular changes in Eales disease. It may also increase the chance of recurrent vitreous hemorrhage or slower recovery after eye treatment.
Poor eating patterns that promote obesity or unstable blood sugar can damage small blood vessels and add extra stress to the retina. If a person with Eales disease also has insulin resistance or diabetes, better nutrition and glucose control may help reduce additional retinal injury.
High salt intake, inactivity, and other habits that raise blood pressure can increase stress on fragile retinal vessels. Better blood pressure control may lower the risk of worsening bleeding and support overall retinal circulation.
Regular moderate exercise supports cardiovascular health and may help blood pressure, weight, and metabolic control, which can benefit retinal vessel health. Very strenuous activity may need caution during active bleeding or recent hemorrhage because sudden pressure changes could worsen symptoms in some patients.
Risk prevention
There is no proven way to fully prevent Eales disease because its exact cause is still not clear. For many people, prevention is really about lowering the risk of flare-ups, bleeding inside the eye, and long-term vision loss through early eye care and treatment of related health issues. Prevention works best when combined with regular check-ups.
Regular visits with an eye specialist can catch retinal inflammation or new abnormal blood vessels before they cause major damage. This can be especially helpful if you have early symptoms of Eales disease, such as floaters, blurred vision, or brief patches of dim sight.
Treating active inflammation or retinal bleeding early may lower the chance of scarring and vision loss. Many living with Eales disease do better when changes in vision are checked right away instead of waiting to see if they pass.
Because Eales disease is sometimes linked with tuberculosis exposure, your doctor may suggest testing when the history or exam points that way. Treating tuberculosis infection when present may reduce ongoing immune irritation that can affect the eyes.
Smoking can harm blood vessels and may add stress to the delicate circulation in the retina. Not smoking, or quitting if you do, supports overall eye and vascular health.
Can you prevent Eales disease?
There is no known way to fully prevent Eales disease, because doctors still do not know exactly why some people develop it. In some people, it may be linked to tuberculosis, so getting checked and treated if you have tuberculosis or possible exposure may help lower risk, but this has not been proven to prevent every case. Regular eye exams can help catch problems early, but they do not prevent the disease itself.
Transmission
Eales disease is not contagious, so it does not spread from one person to another through coughing, touch, sex, blood, food, or shared items. Many living with Eales disease are relieved to hear that close contact with family, friends, classmates, or coworkers does not put others at risk.
People also ask about how Eales disease is inherited, but it is not usually thought of as a disorder passed directly from parent to child in a simple way. Researchers think Eales disease is more likely related to inflammation in the blood vessels of the eye, and in some people this may be linked to the immune system’s response after exposure to certain infections, but the condition itself is not considered infectious.
When to test your genes
For Eales disease, genetic testing is not part of routine early detection or treatment planning because no well-established gene test guides care. If you have vision changes such as floaters, blurred vision, or bleeding in the eye, the right next step is prompt evaluation by an ophthalmologist, not gene testing.
Diagnosis
Eales disease is usually diagnosed after changes in vision, such as new floaters, blurred sight, or a sudden drop in vision, lead to a detailed eye evaluation. It’s natural to worry when symptoms don’t have a clear explanation. In most cases, the diagnosis of Eales disease depends on finding a typical pattern of inflammation and abnormal blood vessels in the retina while also ruling out other causes of retinal bleeding or blockage.
Doctors usually begin by asking about symptoms, how quickly they started, and whether vision changes affect one or both eyes. A detailed family and health history can help uncover other conditions, infections, or medicines that might cause similar retinal problems.
A complete eye exam checks visual sharpness and looks at the front and back of the eye after the pupils are widened with drops. In people with Eales disease, the retina may show inflamed veins, areas with poor blood flow, bleeding, or new fragile blood vessels.
Fluorescein angiography uses a dye and special photographs to show how blood moves through the retinal vessels and where leakage or blockage is happening. This is often central to how Eales disease is diagnosed because it can reveal hidden areas of reduced circulation and abnormal vessel growth.
Optical coherence tomography, often called OCT, creates detailed cross-sectional pictures of the retina. It helps doctors see swelling, bleeding-related changes, or damage near the macula, the part responsible for sharp central vision.
How is Eales disease diagnosed?
Eales disease is usually diagnosed by an eye specialist after a dilated eye exam to look at the retina, the light-sensing layer at the back of the eye, for swollen blood vessels, areas with poor blood flow, bleeding, or fragile new vessels. Doctors often use retinal photos and a dye test called fluorescein angiography, and sometimes scans such as OCT or ultrasound, to see these changes more clearly. There is no single test that proves Eales disease, so the diagnosis also depends on ruling out other causes of similar eye problems, such as diabetes, infections including tuberculosis, blood disorders, or diseases caused by an overactive immune system.
Stages of Eales disease
Eales disease often develops in phases rather than staying the same over time, although the pace can vary from one person to another. In daily life, this may mean blurry vision that seems mild at first, then later episodes of floaters or sudden visual loss from bleeding inside the eye. Many people feel relief once they understand what’s happening. Doctors usually recognize the stages by looking at the retina during an eye exam and using imaging tests to check blood flow and bleeding.
Inflammation stage
The small veins in the outer retina become inflamed, and there may be few symptoms at first. Some people notice mild blurring, eye discomfort, or early symptoms of Eales disease such as floaters. An eye doctor may see vein inflammation even before vision is badly affected.
Blockage stage
Ongoing inflammation can lead to reduced blood flow in parts of the retina. Vision may still seem fairly normal, or you might notice patchy blur and more floaters. The process can involve several steps, each one adding to the picture.
New vessel stage
In response to poor blood flow, the eye may grow fragile new blood vessels. These vessels break easily, so people with Eales disease may suddenly see dark spots, cobweb-like floaters, or a shower of blood in the vision. This stage often causes the most noticeable day-to-day change.
Complication stage
Repeated bleeding and scar tissue can lead to lasting vision problems. Some may develop retinal detachment or severe loss of sight if the pulling on the retina becomes significant. At this point, treatment is often aimed at preventing further damage and preserving as much vision as possible.
Outlook and prognosis
The outlook for people with Eales disease is often fair to good when it is recognized early and monitored closely, but vision can worsen if recurrent retinal inflammation, ischemia, or vitreous hemorrhage are not treated. Many patients have a relapsing course over years, with periods of stability interrupted by new bleeding or progressive retinal neovascularization. Visual prognosis is generally better when laser photocoagulation, corticosteroids, or vitrectomy are used promptly when indicated, although some individuals are left with permanent vision loss from retinal detachment, macular damage, or repeated hemorrhage. The condition usually affects overall life expectancy very little, and deaths directly attributable to Eales disease are considered extremely rare. Long-term follow-up with a retina specialist is important because outcomes depend heavily on disease severity, complications, and timely treatment.
Long-term effects
Eales disease can have a stop-and-start course, with quiet periods followed by new eye bleeding or inflammation. For many, symptoms vary widely, and the long-term outlook depends on how much damage builds up in the retina and whether complications are treated early. Some people keep useful vision for many years, while others develop lasting sight problems in one or both eyes.
Repeated bleeding into the clear gel inside the eye can cause sudden blurring, floaters, or a dark haze that seems to drift across vision. These episodes may clear partly on their own, but repeated bleeding can become a long-term problem in Eales disease.
Over time, repeated inflammation and bleeding can leave some people with permanently weaker eyesight. This may mean trouble reading, driving, or recognizing faces clearly, especially if central vision becomes affected.
Poor blood flow to parts of the retina can lead to fragile new blood vessels that bleed easily. This ongoing lack of oxygen is one reason the long-term effects of Eales disease can build up even between flare-ups.
Scar tissue from abnormal new vessels can pull on the retina and cause it to detach. This is a serious complication that can lead to major, sometimes permanent, vision loss if not treated promptly.
How is it to live with Eales disease?
Living with Eales disease can feel unpredictable because vision may be stable for a while, then suddenly change with new floaters, blurred sight, or bleeding inside the eye. For many people, this can affect reading, driving, work, and confidence in dim light or busy spaces, and it often means regular eye visits and being ready for treatment if the disease becomes active again. The people around you may not always see the problem from the outside, but they may need to help with transportation, appointments, or day-to-day tasks during flare-ups, so open communication and practical support can make a real difference.
Treatment and drugs
Treatment for Eales disease focuses on calming inflammation in the blood vessels of the retina, treating areas with poor blood flow, and managing complications such as bleeding into the eye or retinal detachment. In the active inflammatory phase, doctors often use steroid treatment, sometimes with other medicines that reduce inflammation, while laser treatment can help seal off fragile abnormal vessels and lower the risk of further bleeding. If first-line treatments do not help, specialists may use eye injections or surgery, especially when blood in the vitreous gel does not clear or scar tissue starts pulling on the retina. Not every treatment works the same way for every person, and the best plan often depends on how advanced Eales disease is and whether one or both eyes are affected. Regular follow-up with an eye specialist is an important part of treatment, because early care can help protect vision and reduce the chance of long-term damage.
Can you cure Eales disease?
There is no known cure for Eales disease at this time. Treatment can often control the inflammation, reduce bleeding in the back of the eye, and help protect vision; this may include steroid medicines, laser treatment, or sometimes surgery if the disease is more severe. Many people living with Eales disease need regular care from an eye doctor because it can flare up over time.
Non-drug treatment
Vision changes from Eales disease can disrupt reading, driving, or simply recognizing faces, especially when bleeding inside the eye comes and goes. In Eales disease, non-drug care often centers on eye procedures and close follow-up to protect the retina and preserve sight. Managing this condition often means choosing treatment based on whether the disease is active, whether new fragile blood vessels have formed, and how much bleeding or scar tissue is present.
Regular visits with an eye specialist help track bleeding, blocked blood vessels, and signs of new abnormal vessel growth. For some people with mild or quiet Eales disease, careful observation may be the safest next step until treatment is clearly needed.
Laser treatment can seal off areas of retina that are not getting enough blood, which lowers the drive for fragile new vessels to grow. This is one of the most common procedures used as part of laser treatment for Eales disease and may help reduce the risk of further bleeding.
If blood in the gel inside the eye does not clear, or if scar tissue starts pulling on the retina, surgery may be needed to remove the cloudy gel and relieve traction. Not every approach works the same way, but vitrectomy can be especially helpful when vision is badly blocked by repeated bleeding.
When Eales disease leads to a retinal detachment or severe scar-related damage, additional retinal surgery may be required to reattach and support the retina. The exact procedure depends on what the eye specialist finds and how much of the retina is affected.
Your genes may have an impact on how drugs work for you
For people living with Eales disease, treatment often includes medicines that calm eye inflammation, and some may also receive medicine placed in or around the eye to help control swelling or bleeding. Small inherited differences can sometimes affect how strongly a person responds to these medicines or how likely side effects are, so one person may improve quickly while another needs a different dose or a different treatment plan. Even so, there is no well-established genetic test that routinely guides medicine choice for Eales disease today, so doctors usually adjust treatment based on how the eye responds over time.
Pharmacological treatments
When Eales disease flares, treatment usually aims to calm inflammation in the eye and lower the chance of bleeding from fragile new blood vessels. The medicines used depend on the stage of Eales disease and whether there is active inflammation, reduced blood flow in the retina, or new vessel growth. Not everyone responds to the same medication in the same way. In many people, treatment for Eales disease works best when medicines are paired with close eye follow-up and, when needed, procedures such as laser treatment.
Prednisone by mouth and steroid injections around or into the eye are commonly used when Eales disease is in its active inflammatory phase. These drugs can settle retinal vessel inflammation and may help protect vision if started at the right time. Because they can raise eye pressure, blood sugar, and infection risk, doctors usually monitor closely while they are used.
Ranibizumab, bevacizumab, and aflibercept are injected into the eye to shrink abnormal new blood vessels and reduce leakage or bleeding. They are often used when Eales disease causes retinal neovascularization or vitreous hemorrhage, especially in later stages. Some medicines work quickly, while others may need repeat doses over time.
Methotrexate, azathioprine, mycophenolate mofetil, or cyclosporine may be used if inflammation keeps coming back or if steroids cause troublesome side effects. These medicines help quiet the immune response over a longer period, but they usually take longer to work than steroids. Blood tests and regular follow-up are important while taking them.
Isoniazid, rifampin, pyrazinamide, and ethambutol may be prescribed if testing suggests active tuberculosis or, in some settings, a strong link between Eales disease and tuberculosis exposure. This treatment is not needed for everyone, and the decision depends on eye findings, test results, and local practice. Ask your doctor why a specific drug was recommended for you.
Genetic influences
Most people with Eales disease do not have a known inherited gene change that directly causes it. Genetics is only one piece of the puzzle, but researchers think certain immune-system genes may make some people more likely to develop the inflammation and blood vessel changes linked with Eales disease. In other words, genes may affect susceptibility rather than act as a single clear-cut cause.
Studies have looked at immune-related gene patterns, including some HLA types, but the findings are limited and not strong enough to predict who will get Eales disease. Many living with Eales disease understandably ask what causes Eales disease, because infections, immune reactions, and other non-genetic factors also seem to matter. There is no well-established family inheritance pattern, so genetic testing is not usually part of standard care.
Is Eales disease genetic?
Genetics do not appear to be the main cause of Eales disease. Some genetic variations may affect immune responses and susceptibility, but the exact role of inherited factors in Eales disease is still unclear.
Having a genetic risk is not necessarily a diagnosis
Gene changes are a normal part of human biology and are common throughout the general population. Most of these changes do not directly affect health and are simply part of natural human diversity. For many genes, having a change associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, one well-studied change in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For people living with Eales disease, treatment decisions are not usually guided by genetic test results in the way they are for some other conditions. Doctors mainly choose treatment based on what is happening in the eye at that moment, such as active inflammation, poor blood flow in the retina, new fragile blood vessels, or bleeding, and this may include steroid medicines, laser treatment, eye injections, or sometimes surgery. Not every difference in response is genetic, but people with Eales disease can still respond differently to the same medicine, partly because the disease can be at a different stage from one person to another. Researchers have looked at whether immune-related genes may play a role in who develops Eales disease, yet there is no widely accepted pharmacogenetic test that can reliably predict which drug will work best or who will get side effects. For many, this can mean some trial and adjustment with treatment, along with close follow-up to see how the retina responds over time. If you are wondering about genetic testing for Eales disease treatment, it is best to ask your eye specialist what is useful now and what is still mainly being studied.
Interactions with other conditions
Blurred vision or new floaters from Eales disease can be especially confusing when someone also has another condition that affects the eyes or blood vessels. Another important aspect is how it may link with other diseases. Doctors often look for tuberculosis, because Eales disease has long been associated with past or active TB infection in some people, and that can affect whether testing or treatment is needed. Diabetes and high blood pressure do not cause Eales disease, but if they are present, they can also harm the retina and may make episodes of bleeding, poor vision, or the early symptoms of Eales disease harder to sort out. Eye doctors may also check for other inflammatory, autoimmune, or blood-clotting conditions, mainly to be sure the retinal changes are truly due to Eales disease and not a different illness that can look similar. For many living with Eales disease, this means care may involve both an eye specialist and another doctor if an infection or another health issue needs attention.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Eales disease?
Other eye problems can look a lot like Eales disease, especially diabetic eye disease, a blocked vein in the light-sensitive layer at the back of the eye, and sickle cell-related eye damage, because all of these can cause floaters, blurry vision, bleeding inside the eye, or sudden vision loss. Doctors also think about other causes of eye blood vessel inflammation, including conditions linked to tuberculosis, sarcoidosis, or Behcet disease. In some people, a retinal tear or detachment can also cause sudden changes in vision and may need to be ruled out quickly.
History
For many living with Eales disease, the first thing that matters is not the name but the experience: episodes of blurred vision, floaters, or suddenly noticing dark spots that make reading, driving, or recognizing faces harder. Long before modern eye imaging, doctors had to piece the condition together from these everyday vision changes and from what they could see during an eye exam.
Eales disease was first described in the medical literature in the late 1800s by the British doctor Henry Eales, who reported recurring bleeding in the retina, the light-sensitive layer at the back of the eye, in otherwise healthy young adults. Early reports focused on repeated retinal bleeding and inflammation in the veins of the retina. At that stage, doctors could describe what they saw, but they did not yet fully understand why it happened or why some people had repeated flare-ups.
As medical science evolved, the picture became clearer. Over time, eye specialists recognized that Eales disease usually follows a pattern of inflammation, reduced blood flow in parts of the retina, and then growth of fragile new blood vessels that can bleed into the eye. This helped explain why some may find that vision comes and goes, especially after a fresh bleed, while others have a quieter course for long periods.
The way Eales disease has been understood has changed over the years. In the past, doctors often debated whether it was a form of infection, a reaction to earlier exposure to certain germs, or a separate inflammatory eye disease. Today, it is generally viewed as an inflammatory disease affecting the retinal blood vessels, and in some parts of the world researchers have noted links with prior exposure to tuberculosis. Not every early description was complete, yet together they helped build the modern view of Eales disease and improved the way it is diagnosed and monitored.